How to appeal a Blue Cross Blue Shield of Michigan interventional pain — scs, rfa, esi, kyphoplasty denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross Blue Shield of Michigan-specific note: Largest insurer in Michigan (~4.5M members). Statutory non-profit mutual. Switched PBM from Express Scripts to OptumRx effective January 2024 — appeals around 2024-2025 may involve formulary disruption. Michigan DIFS oversight.

What Blue Cross Blue Shield of Michigan's policy requires for interventional pain — scs, rfa, esi, kyphoplasty

Cited policy: Anthem clinical guideline (SCS) + clinical guideline (RFA) + BCBS medical policy (SI Joint Fusion) + BCBS medical policy (Vertebroplasty)

Budapest Criteria for CRPS; SI fusion requires dual diagnostic SI injections >=75%.

How Blue Cross Blue Shield of Michigan denies interventional pain — scs, rfa, esi, kyphoplasty — and how to counter it

Where Blue Cross Blue Shield of Michigan pushes back: 1) CRPS not meeting Budapest in chart; 2) SI fusion missing dual injections >=75%; 3) Kyphoplasty fracture >6wk old or no STIR edema.

Counter-arguments that hold up: Add explicit Budapest Criteria checklist signed by physician. Submit two SI joint diagnostic injection reports with quantified relief. For kyphoplasty: STIR/T2 edema, ongoing pain >=NRS 5 despite conservative care, VERTOS IV trial data refuting 'self-limited' rationale.

What Blue Cross Blue Shield of Michigan typically denies for interventional pain — scs, rfa, esi, kyphoplasty

Across Blue Cross Blue Shield of Michigan's commercial and Medicare books, denials cluster around a small number of patterns. For interventional pain — scs, rfa, esi, kyphoplasty, expect:

• Step therapy via OptumRx (PBM since 2024)
• Site-of-care reductions for infusions
• Behavioral health prior auth
• OON balance bill disputes

Treatments most often denied in this category

These are the interventional pain — scs, rfa, esi, kyphoplasty treatments most often flagged for prior auth, step therapy, or medical necessity review:

• SCS (Tonic)
• HF10/Burst SCS
• DRG stimulator
• Intrathecal pump
• Peripheral nerve stim
• Lumbar RFA

How to submit the appeal to Blue Cross Blue Shield of Michigan

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross Blue Shield of Michigan cited in the denial.
3. File the appeal through Blue Cross Blue Shield of Michigan's portal (members: https://www.bcbsm.com ; providers: https://providers.bcbsm.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MI, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross Blue Shield of Michigan's prior-authorization criteria by drug: Blue Cross Blue Shield of Michigan PA criteria on ApprovalHelp.